Stanislav Sirakov's guest appearances

Stanislav Sirakov

Faces of Digital Health

5 pitanja za...

Benedict Evans

Dean Ornish

Chris Bowen

Chris Johnson

Amy Brown

Richard Lee

Esther Wojcicki

Samson Williams

Tim Peck

Esther Dyson

Richard Jacobs

Bill Rogers

Robert Miller

Casey Ross

Walter Werzowa

OwlTail

Epizoda je na engleskom jeziku. Finansijski direktor, pretvoren u preduzetnika, pretvorio se u investitora. Tokom poslednjih 8 godina (od početka LAUNCHub Ventures-a), Stan ulaže u tehnološke kompanije u jugoistočnoj Evropi. Sedeći u odborima Gtmhub-a (podignuta Serija A sa CRV-om), Cleanshelf (podignuta Serija A sa Dawn Capital-om), Tailor &amp; Hart (podignuta Serija A sa Active Partners), Ferryhopper-u, Mediately-ju i nekoliko drugih portfolio kompanija, sa posebnim interesovanjem za b2b softver, korporativni SaaS, AI i način na koji tehnologija menja tradicionalne industrije. Diplomiravši računarstvo 2001. godine, Stanislav je započeo karijeru u finansijskoj industriji u Allianz-u, nemačkoj osiguravajućoj grupi, u odeljenju za upravljanje rizicima. Kasnije je prešao na upravljanje razvojem prodaje. 2007. godine napustio je kompaniju u fintech sektoru. Mnogo lekcija naučio na teži način, ali stekao neprocenjivo iskustvo u timskom i organizacionom razvoju, izgradnji partnerstva i prikupljanju sredstava. LAUNCHub Ventures je vodeći fond rizičnog kapitala, za startape u ranoj fazi, koji ulaže u centralnu i jugoistočnu Evropu i njenu dijasporu u velikim habovima. Sa više od 75 miliona evra pod upravljanjem, LHV podržava osnivače sa globalnim ambicijama da ostvare svoj puni potencijal. Stan je odgovorio na 5 pitanja koja ste postavili tokom sedmice. How do you define and determine which startup will be a potential and a good investment?How often investors think that founder or CEO of the startup won't be able to run business in few years and why?Do you invest in Serbian startups and if you do or did, what's your experience with it?How startups know how much money do they need and how they will further scale?Can you name 3 the most common reasons that investors reject startups? Hvala Epson Srbija i Nova Iskra na podršci u realizaciji ovog podcasta!

Epizoda je na engleskom jeziku. Finansijski direktor, pretvoren u preduzetnika, pretvorio se u investitora. Tokom poslednjih 8 godina (od početka LAUNCHub Ventures-a), Stan ulaže u tehnološke kompanije u jugoistočnoj Evropi. Sedeći u odborima Gtmhub-a (podignuta Serija A sa CRV-om), Cleanshelf (podignuta Serija A sa Dawn Capital-om), Tailor &amp; Hart (podignuta Serija A sa Active Partners), Ferryhopper-u, Mediately-ju i nekoliko drugih portfolio kompanija, sa posebnim interesovanjem za b2b softver, korporativni SaaS, AI i način na koji tehnologija menja tradicionalne industrije. Diplomiravši računarstvo 2001. godine, Stanislav je započeo karijeru u finansijskoj industriji u Allianz-u, nemačkoj osiguravajućoj grupi, u odeljenju za upravljanje rizicima. Kasnije je prešao na upravljanje razvojem prodaje. 2007. godine napustio je kompaniju u fintech sektoru. Mnogo lekcija naučio na teži način, ali stekao neprocenjivo iskustvo u timskom i organizacionom razvoju, izgradnji partnerstva i prikupljanju sredstava. LAUNCHub Ventures je vodeći fond rizičnog kapitala, za startape u ranoj fazi, koji ulaže u centralnu i jugoistočnu Evropu i njenu dijasporu u velikim habovima. Sa više od 75 miliona evra pod upravljanjem, LHV podržava osnivače sa globalnim ambicijama da ostvare svoj puni potencijal. Stan je odgovorio na 5 pitanja koja ste postavili tokom sedmice. <ol><li>How do you define and determine which startup will be a potential and a good investment?</li><li>How often investors think that founder or CEO of the startup won't be able to run business in few years and why?</li><li>Do you invest in Serbian startups and if you do or did, what's your experience with it?</li><li>How startups know how much money do they need and how they will further scale?</li><li>Can you name 3 the most common reasons that investors reject startups?</li></ol> Hvala <a href="https://www.linkedin.com/company/epson-srbija/" rel="nofollow" target="_blank">Epson Srbija</a> i <a href="https://www.linkedin.com/company/nova-iskra/" rel="nofollow" target="_blank">Nova Iskra</a> na podršci u realizaciji ovog podcasta!

5 pitanja za... Stanislav Sirakov

Axel Polack

Klaus Stöckemann

Dorjan Marušič

Alex Farcet

According to some estimates, it takes 17 years from a medical innovation to become a part of the standard practice in medicine. Adoption of technologies in healthcare is slow. Investments in digital health are rising - 8 billion USD was invested last year. But what does that even mean? What works, what not? What have we learned in the past years about business models in digital health? This was the topic of a Panel at INFUSE Digital Health Networking Event, organized in Ljubljana in May 2017. Top KOLs talked about why patients are different consumers than payers in other industries, what challenges are specific for digital health startups, and which mistakes are the same here as with the other startups.Speakers: Dr. Jesus del Valle, Head of Bayer’s Grants4Apps AcceleratorDr. Axel Polack, General Partner at the Joint Polish Investment fundDr. Klaus Stöckemann, the Managing Partner at Peppermint Venture PartnersDorjan Marušič, Practicing Cardiologist, Former Health Minister of SloveniaStanislav Sirakov, Partner at LAUNCHubAlex Farcet, Co-founder of Startupbootcamp Info/comments welcome at: @zajctjasa or tjasa.zajc@gmail.com

According to some estimates, it takes 17 years from a medical innovation to become a part of the standard practice in medicine. Adoption of technologies in healthcare is slow. Investments in digital health are rising - 8 billion USD was invested last year. But what does that even mean? What works, what not? What have we learned in the past years about business models in digital health? This was the topic of a Panel at INFUSE Digital Health Networking Event, organized in Ljubljana in May 2017. Top KOLs talked about why patients are different consumers than payers in other industries, what challenges are specific for digital health startups, and which mistakes are the same here as with the other startups. Speakers:  Dr. Jesus del Valle, Head of Bayer’s Grants4Apps Accelerator Dr. Axel Polack, General Partner at the Joint Polish Investment fund Dr. Klaus Stöckemann, the Managing Partner at Peppermint Venture Partners Dorjan Marušič, Practicing Cardiologist, Former Health Minister of Slovenia Stanislav Sirakov, Partner at LAUNCHub Alex Farcet, Co-founder of Startupbootcamp   Info/comments welcome at: @zajctjasa or tjasa.zajc@gmail.com

012 Rethinking Business Models in Healthcare. Patients as Consumers? (Jesus del Valle, Axel Polack, Klaus Stöckemann, Dorjan Marušič, Stanislav Sirakov, Alex Farcet)